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Abstract. 
 
Previously we have demonstrated that focal 
adhesion kinase (FAK)-promoted migration on fi-
bronectin (FN) by its overexpression in CHO cells is 
dependent on FAK autophosphorylation at Y397 and 
subsequent binding of Src to this site. In this report, we 
have examined the role of FAK association with Grb2 
and p130
 
Cas
 
, two downstream events of the FAK/Src 
complex that could mediate integrin-stimulated activa-
tion of extracellular signal-regulated kinases (Erks). 
We show that a Y925F FAK mutant was able to pro-
mote cell migration as efficiently as FAK and that the 
transfected FAK demonstrated no detectable associa-
tion with Grb2 in CHO cells. In contrast, cells express-
ing a FAK P712/715A mutant demonstrated a level of 
migration comparable to that of control cells. This mu-
tation did not affect FAK kinase activity, autophos-
phorylation, or Src association but did significantly re-
duce p130
 
Cas
 
 association with FAK. Furthermore, FAK 
expression in CHO cells increased tyrosine phosphory-
lation of p130
 
Cas
 
 and its subsequent binding to several 
SH2 domains, which depended on both the p130
 
Cas
 
 
binding site and the Src binding site. However, we did 
not detect increased activation of Erks in cells express-
ing FAK, and the MEK inhibitor PD98059 did not de-
crease FAK-promoted cell migration. Finally, we show 
that coexpression of p130
 
Cas
 
 further increased cell mi-
gration on FN and coexpression of the p130
 
Cas
 
 SH3 do-
main alone functioned as a dominant negative mutant 
and decreased cell migration. Together, these results 
demonstrate that p130
 
Cas
 
, but not Grb2, is a mediator of 
FAK-promoted cell migration and suggest that FAK/
p130
 
Cas
 
 complex targets downstream pathways other 
than Erks in mediating FAK-promoted cell migration.
 
F
 
ocal
 
 adhesion kinase (FAK)
 
1
 
 is a cytosolic protein
tyrosine kinase that is critical in integrin-mediated
signal transduction pathways (Clark and Brugge,
1995; Schwartz et al., 1995; Parsons, 1996). It is localized to
focal contacts in many adherent cells in culture and be-
comes activated and tyrosine phosphorylated in response
to cell adhesion to extracellular matrix (ECM) proteins in
a variety of cell types (Schwartz et al., 1995). FAK associ-
ates with a number of signal transduction molecules, in-
cluding Src and related kinases (Cobb et al., 1994; Xing
et al., 1994), Grb2 (Schlaepfer et al., 1994), p130
 
Cas
 
 (Polte
and Hanks, 1995), and phosphatidylinositol 3-kinase (PI
3-kinase) (Chen and Guan, 1994). It also associates with
the focal contact and cytoskeletal proteins paxillin (Turner
and Miller, 1994; Schaller and Parsons, 1995) and talin (Chen
et al., 1995) and is believed to associate with tensin (Miya-
moto et al., 1995). Its interactions with these and poten-
tially other proteins mediate FAK’s functions in integrin-
dependent signal transduction.
Upon activation, FAK becomes autophosphorylated with
the major site being Y397, which serves as a binding site
for the Src homology 2 (SH2) domain of Src and related
kinases (Chan et al., 1994; Schaller et al., 1994) as well as
the SH2 domains of the regulatory subunit (p85) of PI
3-kinase (Chen et al., 1996). Upon binding to Y397, Src
further phosphorylates FAK at several sites including
Y925, which serves as a binding site for the SH2 domain of
the Grb2 adaptor protein (Schlaepfer et al., 1994;
Schlaepfer and Hunter, 1996). The direct binding of Grb2
to FAK has been proposed to initiate downstream signal-
ing pathways, resulting in activation of extracellular signal-
regulated kinases (Erks) (Schlaepfer et al., 1994), which
have been shown to be activated in cell adhesion (Chen et
al., 1994; Schlaepfer et al., 1994; Zhu and Assoian, 1995).
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1. 
 
Abbreviations used in this paper
 
: CasSH3, SH3 domain of p130
 
Cas
 
;
ECM, extracellular matrix; Erks, extracellular signal-regulated kinases;
FAK, focal adhesion kinase; FN, fibronectin; GST, glutathione S-trans-
ferase; PI 3-kinase, phosphatidylinositol 3-kinase; SH2 and SH3, Src ho-
mology 2 and 3.
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p130
 
Cas
 
 is another signal transduction protein that binds
directly to FAK. It is an adaptor protein, containing an Src
homology 3 (SH3) domain as well as multiple phosphoty-
rosine motifs for binding a variety of SH2 domains (Sakai
et al., 1994). It is phosphorylated upon cell adhesion to
ECM (Nojima et al., 1995; Petch et al., 1995; Vuori and
Ruoslahti, 1995) and in a FAK- and Src-dependent man-
ner (Vuori et al., 1996; Schalepfer et al., 1997). The pro-
line-rich region of FAK spanning amino acids 712–718 has
been mapped as a binding site for the SH3 domain of
p130
 
Cas
 
 (Polte and Hanks, 1995; Harte et al., 1996). FAK
association with p130
 
Cas
 
 has also been proposed to initiate
a signal transduction pathway to activate Erks (Schlaepfer
et al., 1997).
FAK is clearly an important regulator of integrin signal
transduction, and recently its roles in specific cellular func-
tions have begun to be elucidated. It has been proposed to
regulate cell spreading because when it is inhibited by ex-
pression of its noncatalytic carboxy-terminal domain in
chicken embryo fibroblasts, the rate of cell spreading is de-
layed (Richardson and Parsons, 1996). It has also been
suggested to play a role in ECM-mediated apoptosis and
cell proliferation (Frisch et al., 1996; Gilmore and Romer,
1996; Hungerford et al., 1996). However, more evidence
exists to demonstrate that FAK plays a crucial and specific
role in cell migration events. Inhibition of endogenous FAK
by microinjection of its carboxy-terminal domain in endo-
thelial cells resulted in decreased cell migration (Gilmore
and Romer, 1996). Likewise, cultured fibroblasts isolated
from FAK null mice, which demonstrated an embryonic
lethal phenotype, showed markedly reduced cell motility
in vitro (Ilic et al., 1995). Similarly, we have recently dem-
onstrated that stable overexpression of FAK in CHO cells
resulted in increased migration (Cary et al., 1996).
Using the FAK overexpression system in CHO cells has
enabled us to examine the molecular mechanisms of FAK
signal transduction. We have found that phosphorylation
of Y397 of FAK and subsequent Src binding are crucial for
its role in signal transduction resulting in cell migration.
CHO cells expressing the FAK point mutant Y397F, which
did not bind Src, demonstrated a basal level of cell migra-
tion, while a kinase-defective FAK mutant that was tyro-
sine phosphorylated and associated with Src was able to
promote CHO cell migration (Cary et al., 1996). Interest-
ingly, Klemke et al. (1997) have recently reported that ac-
tivation of Erks regulates cell migration on ECM by di-
rectly phosphorylating a cytoplasmic target myosin light
chain kinase. Because both Grb2 and p130
 
Cas
 
 have been
proposed to activate Erks in a manner dependent on the
FAK/Src complex, we investigated the potential role of
FAK association with Grb2 and/or p130
 
Cas
 
 in mediating
the FAK-promoted cell migration in the present study.
 
Materials and Methods
 
Antibodies
 
The mouse mAb KT3 (Cary et al., 1996), the mouse mAb 12CA5 (Chen
et al., 1995), and the rabbit polyclonal anti-FAK serum (Chen and Guan,
1994) have been described previously. The following antibodies were pur-
chased as indicated: rabbit anti-p130
 
Cas
 
 (C-20) from Santa Cruz Biotech-
nology, Inc. (Santa Cruz, CA); anti-Src mouse mAb 2-17 from Quality
Biotech (Camden, NJ); antiphosphotyrosine mouse mAb PY20 from Trans-
duction Laboratories (Lexington, KY); rabbit anti–phospho-MAPK from
New England Biolabs, Inc. (Beverly, MA); and mouse mAb 9E10, which
recognizes the c-Myc epitope tag (EQKLISEEDL), from Calbiochem (La
Jolla, CA).
 
Construction of Expression Plasmids
 
The expression plasmid pCDM8-FAK has been described previously
(Cary et al., 1996). The FAK point mutant Y925F was generated using over-
lap extension by the polymerase chain reaction as described previously
(Ho et al., 1989). The sense (5
 
9
 
-CCCACCCTCTTCAGCCTTATG-3
 
9
 
)
and antisense (5
 
9
 
-CTTGTACTCCTGCTGCAGGCTGG-3
 
9
 
) oligonucle-
otides were used as amplification primers, and the mutation was intro-
duced using the sense (5
 
9
 
-ATGACAAAGTCTTTGAGAATGTAAC-3
 
9
 
)
and its complementary antisense oligonucleotide as internal mismatch
primers. The product of the PCR mutagenesis was then ligated to pBlue-
script-FAK (a generous gift from Dr. J. Thomas Parsons, University of
Virginia, Charlottesville, VA) after digestion of each with NdeI and NheI.
Generation of the mutation was verified by dideoxy DNA sequencing
(United States Biochemical Corp., Cleveland, OH). The MscI-NheI frag-
ment containing the mutation was then subcloned into pCDM8-FAK,
from which the MscI-NheI fragment had been removed, and the resulting
plasmid was designated pCDM8-Y925F. The P712/715A double point
mutant was similarly generated, using the sense (5
 
9
 
-CCCACCCTCTTCA-
GCCTTATG-3
 
9
 
) and antisense (5
 
9
 
-CTTGTACTCCTGCTGCAGGC-
TGG-3
 
9
 
) oligonucleotides as amplification primers, and the sense (5
 
9
 
-CAG-
ATGAAGCTGCTCCCAAGGCCAGCAGGCC-3
 
9
 
) and its complementary
antisense oligonucleotide as internal mismatch primers. The PCR product
was ligated into pBluescript using EcoRV, the AccI-NheI fragment con-
taining the mutation was subcloned to pBluescript-FAK, and finally the
MscI-SalI fragment was ligated into pCDM8-FAK, from which this wild-
type sequence had been removed. The resulting plasmid was designated
pCDM8-P712/715A.
The pKH3 and pKH3-FAK vectors were described previously (Chen
et al., 1996). The SH3 domain of p130
 
Cas
 
 was PCR amplified from pVP16-
cas 1a-2 (Polte and Hanks, 1995) using the forward and reverse primers
5
 
9
 
-GCGGATCCATGAAGTACCTGAACGTGC-3
 
9
 
 and 5
 
9
 
-GCGAAT-
TCTCCTGCTGGCTTCTTATC-3
 
9
 
. The PCR reaction was carried out
using Deep Vent DNA polymerase, digested with BamHI and EcoRI, and
cloned into pKH3 to generate pKH3-CasSH3. The hygromycin-resistance
vector pREP3 was a generous gift of Dr. Andrew Yen (Cornell University,
Ithaca, NY).
Plasmid pRc/CMV-Cas(Myc) was constructed by inserting the full-
length mouse Cas cDNA (GenBank/EMBL/DDBJ accession number
U28151; Polte and Hanks, 1995) into the NotI site of eukaryotic expres-
sion vector pRc/CMV (Invitrogen, Carlsbad, CA). The Cas cDNA was
engineered to encode an additional short sequence including the human
c-Myc epitope, GREQKLISEEDLRGRLA, inserted two amino acid resi-
dues upstream of the Cas carboxyl terminus. A Myc-epitope cassette was
generated by annealing partially complementary oligonucleotides (coding:
5
 
9
 
-CTAGCCGGCCGCGAGCAGAAGCTGATCTCCGAGGAGGAC-
CTCCGCGGCCGG-3
 
9
 
; noncoding: 5
 
9
 
-CTAGCCGGCCGCGGAGGT-
CCTCCTCGGAGATCAGCTTCTGCTCGCGGCCGG-3
 
9
 
) to produce
a double-stranded cDNA with overhanging NheI-compatible ends. The
cassette was ligated into the NheI site located near the 3
 
9
 
-end of the Cas
coding sequence before subcloning into pRc/CMV.
 
Cells and Transfections
 
CHO cells were maintained in F-12 medium with 10% FBS (both from
GIBCO BRL, Gaithersburg, MD). Cells expressing wild-type (WT), ki-
nase-defective (KD), or Y397F FAK as well as control cells (Neo) have
been described previously (Cary et al., 1996). To generate cells stably ex-
pressing either the Y925F or P712/715A FAK mutant, CHO cells grown
on 35-mm dishes were transfected essentially as described previously
(Cary et al., 1996) using lipofectamine (GIBCO BRL) and following the
manufacturer’s instructions. Briefly, 1 
 
m
 
g of either pCDM8-Y925F or
pCDM8-P712/715A and 0.1 
 
m
 
g of pSV2neo were transfected, and neomy-
cin-resistant cells were selected using growth medium containing 0.5 mg/
ml G418 (GIBCO BRL). Clones were selected and screened for exoge-
nous FAK expression by indirect immunofluorescence and Western blot-
ting using the mAb KT3.
To generate cells stably expressing both FAK and wild-type p130
 
Cas
 
(WT/Cas cells), WT cells were transfected as described above using lipo-
fectamine, 1 
 
m
 
g of pRc/CMV-Cas(Myc), and 0.1 
 
m
 
g of pREP3. Clones 
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were selected in growth medium containing 0.5 mg/ml G418 and 0.8 mg/ml
Hygromycin B (Sigma Chemical Co., St. Louis, MO) and screened for
FAK and p130
 
Cas
 
 expression by Western blotting with KT3 and 9E10, re-
spectively. Likewise, cells stably expressing both FAK and CasSH3 (WT/
CasSH3 cells) were generated by transfection with lipofectamine, 1 
 
m
 
g of
pKH3-CasSH3, and 0.1 
 
m
 
g of pREP3 and selected as above for WT/Cas
cells. Cells were screened for FAK and CasSH3 expression by Western
blotting with KT3 and 12CA5, respectively.
Human embryonic kidney 293 cells were maintained in DME with 10%
FBS (both from GIBCO BRL). Transient transfection of 293 cells grown
on 10-cm dishes was carried out similarly using lipofectamine and 9 
 
m
 
g of
either pKH3-FAK or pCDM8-FAK. Lysates were generated from these
cells 2 d after transfection.
 
Immunoprecipitations, Western Blots, and In Vitro 
Kinase Assays
 
For most experiments, attached cells were lysed in NP-40 lysis buffer con-
taining protease inhibitors (Cary et al., 1996). For the Erk activation ex-
periment, some cells were harvested by brief treatment with trypsin,
which was inhibited by soybean trypsin inhibitor (0.5 mg/ml) and washed,
followed by lysis as suspended cells in NP-40 lysis buffer. For coimmuno-
precipitation of FAK with endogenous p130
 
Cas
 
, attached cells were lysed
in modified RIPA buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 5 mM
EDTA, 1% NP-40, 1 mM sodium vanadate, 0.5% sodium deoxycholate,
and 0.05% SDS) containing protease inhibitors (1 mM PMSF, 0.1 trypsin
inhibitory U/ml aprotinin, and 20 
 
m
 
g/ml leupeptin). For detection of FAK-
promoted phosphorylation of p130
 
Cas
 
 and binding to SH2 domains, cells
were treated with 50 
 
m
 
M sodium vanadate (a tyrosine phosphatase inhibi-
tor) for 16 h at 37
 
8
 
C as described previously (Schaller and Parsons, 1995)
followed by lysis in NP-40 lysis buffer. Lysates were cleared by centrifuga-
tion, and total protein concentrations were determined using Bio-Rad
Protein Assay (Hercules, CA).
Immunoprecipitations (Cary et al., 1996) and in vitro kinase assays
(Guan and Shalloway, 1992) were carried out as described previously. For
coimmunoprecipitation of the p130
 
Cas
 
 SH3 domain with FAK, SDS-
PAGE was performed under nonreducing conditions to eliminate comi-
gration of the antibody light chain with the SH3 domain. Western blotting
was also carried out as before (Guan et al., 1991) using dilutions of 1:2,000
for KT3 mouse ascites fluid, 1:1,000 for anti-p130
 
Cas
 
, 1:1,000 for PY20, 1:600
for 12CA5 mouse ascites fluid, 1 
 
m
 
g/ml for 9E10, 1:5,000 for anti-FAK,
and 1:2,000 for anti–phospho-MAPK.
 
Cell Migration Assays
 
Migration assays in 48-well chemotaxis chambers (Neuro Probe, Inc.,
Cabin John, MD) were carried out as described previously (Cary et al.,
1996). Briefly, human plasma fibronectin (FN) at various concentrations
was added to the lower wells. Cells were harvested by brief trypsinization,
washed, and added to the upper wells of the chamber, which were sepa-
rated from the lower wells by a polycarbonate membrane. Cells were al-
lowed to migrate for 6 h at 37
 
8
 
C. The membrane was fixed and stained,
unmigrated cells were removed by wiping the upper side of the mem-
brane, and the migrated cells were counted under a light microscope at
200
 
3
 
 magnification. For experiments using the MEK inhibitor PD98059
(New England Biolabs, Inc.), cells were harvested and washed as above,
resuspended in F-12 medium containing the indicated concentrations of
PD98059, and pretreated for 1 h at 37
 
8
 
C. Without removing the PD98059,
the cells were then added to the chemotaxis chamber and allowed to mi-
grate to FN as above.
 
Expression of Glutathione S-Transferase Fusion 
Proteins and In Vitro Binding Assays
 
The pGEX-Src-SH2, pGEX-Grb2-SH2, and pGEX-p85-NSH2 plasmids
were described previously (Chen et al., 1996). The pGEX-Nck-SH2 vector
was kindly provided by Dr. Wei Li (University of Chicago, Chicago, IL).
Expression and affinity purification of glutathione S-transferase (GST) fu-
sion proteins were carried out essentially as described previously (Xing
et al., 1994). Briefly, bacteria harboring the indicated expression vector
were cultured at 37
 
8
 
C in medium containing 40 
 
m
 
g/ml ampicillin, isopropyl
 
b
 
-
 
d
 
-thiogalactopyranoside (IPTG) was then added to a concentration of
0.15 mM, and the bacteria were cultured for an additional 2 h. Cells were
centrifuged, resuspended in PBS containing 1% Triton X-100, and lysed
by sonication. The lysates were cleared by centrifugation, and GST fusion
proteins were affinity purified using glutathione-Sepharose beads, which
were then washed three times and resuspended in NP-40 lysis buffer. For
in vitro binding assays, cell lysates in NP-40 lysis buffer were incubated
with the indicated GST fusion protein beads for 2–3 h at 4
 
8
 
C, the beads
were washed with NP-40 lysis buffer, and bound proteins were eluted by
boiling in SDS sample buffer and then detected by Western blotting.
 
Results
 
Grb2 Binding to Y925 of FAK Is Not Necessary for 
FAK-promoted Cell Migration
 
To examine the potential role of FAK association with
Grb2 in its ability to promote cell migration, we created a
FAK mutant replacing Y925 with F using site-directed mu-
tagenesis as described in Materials and Methods. Since
Y925 of FAK has been mapped as the binding site for
Grb2 in cell adhesion (Schlaepfer et al., 1994; Schlaepfer
and Hunter, 1996), this mutation (designated Y925F) is pre-
dicted to disrupt FAK binding to Grb2. The expression
vector pCDM8-Y925F with epitope tags was cotransfected
with pSV2neo to CHO cells as described in Materials and
Methods. Multiple clones were analyzed for expression of
exogenous FAK by indirect immunofluorescent staining
and Western blotting using KT3, a mAb against the epi-
tope tag. Fig. 1 
 
A
 
 shows expression of the mutant FAK in
two independent Y925F cell clones as detected by West-
ern blotting with KT3. The level of the mutant FAK ex-
pression in these two clones was comparable to that in a
clone overexpressing wild-type FAK (WT), described pre-
viously (Cary et al., 1996). As expected, KT3 did not rec-
ognize the endogenous FAK in control CHO cells (Neo).
To determine the effects of this FAK mutation on its
ability to promote cell migration, these two clones express-
ing Y925F FAK were analyzed by modified Boyden cham-
ber assays using FN as an attractant (Fig. 1 
 
B
 
), as de-
scribed previously (Cary et al., 1996). As expected, the
WT cells exhibited an increased level of migration as com-
pared with the control clone (Neo). At two different FN
concentrations, both clones expressing the Y925F FAK
mutant also demonstrated an increased level of migration
that was comparable to that of WT cells. These results
demonstrated that Y925 was not necessary for FAK-pro-
moted cell migration and suggested that Grb2 binding to
FAK and its downstream signaling pathways were dispens-
able for integrin-mediated cell migration.
To examine the ability of FAK to bind Grb2 in our
CHO cell system, we carried out coimmunoprecipitation
experiments, but we were unable to detect exogenous FAK
association with Grb2 in these cells (data not shown). To
rule out the possibility that there was a weak but undetect-
able interaction of Grb2 with FAK, we carried out in vitro
binding experiments as shown in Fig. 2. Lysates prepared
from cells overexpressing wild-type FAK, Y397F mutant
FAK (described previously by Cary et al., 1996), Y925F
mutant FAK, or control cells (Neo) were used for in vitro
binding experiments with the indicated GST fusion pro-
teins, and bound FAK was detected by Western blotting
with KT3 (Fig. 2 
 
A
 
). There was no detectable binding of
exogenous FAK in CHO cells with the Grb2-SH2 domain.
As a control for this experiment, the same lysates were
used for a binding assay with the Src-SH2 domain, demon-
strating that the exogenous FAK was able to bind GST- 
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Src-SH2 and furthermore that this binding was dependent
on the Src-binding site of FAK (Y397) but not the Grb2
binding site (Y925). No binding of FAK to GST alone was
detected.
These results indicated that one or both of the epitope
tags on the exogenous FAK may disrupt its binding to
Grb2. To examine this possibility, lysates from 293 cells
transiently transfected with the indicated FAK expression
vectors were used for an in vitro binding assay with GST
fusion proteins, as above, and the bound FAK was de-
tected by Western blotting with anti-FAK (Fig. 2 
 
B
 
). The
pCDM8-FAK construct, which was used to generate the
CHO WT cells, results in a FAK protein tagged with one
HA epitope at the amino terminus and one T-antigen epi-
tope at the carboxy terminus. The pKH3-FAK construct re-
sults in a FAK protein tagged with three repeats of the
HA epitope at the amino terminus and no epitope at the
carboxy terminus. As shown in Fig. 2 
 
B
 
, FAK expressed by
the pKH3-FAK construct was able to bind the Grb2-SH2
domain in vitro, while FAK expressed by the pCDM8-
FAK construct was not. No significant binding of either
FAK protein was detected to GST alone. These results
demonstrated that the exogenous FAK expressed in CHO
cells was not able to bind Grb2, and that this binding may
have been disrupted by the carboxy-terminal epitope tag
on FAK. These results further support that Grb2 binding
to Y925 of FAK is not necessary for the ability of FAK to
promote CHO cell migration.
 
P712 and P715 of FAK Are Necessary for Its Ability to 
Promote Cell Migration
 
The proline-rich region of FAK spanning amino acids
712–718 has been mapped as a binding site for the SH3 do-
main of p130
 
Cas
 
 (Polte and Hanks, 1995; Harte et al., 1996).
To examine the role of p130
 
Cas
 
 binding to FAK in cell mi-
gration, a FAK mutant P712/715A was generated convert-
ing the two critical prolines P712 and P715 to alanines. The
expression vector pCDM8-P712/715A was transfected to
CHO cells, and multiple clones expressing this FAK mutant
were selected as described in Materials and Methods.
Western blotting with KT3 showed that two independent
clones expressing this FAK mutant (P712/715A-1 and
P712/715A-2) contained similar levels of exogenous FAK
compared with cells expressing wild-type FAK (WT) (Fig.
3 
 
A
 
). These two clones were then subjected to cell migra-
Figure 1. Grb2 binding to Y925 of FAK does not mediate FAK-
promoted cell migration. (A) Cell lysates were generated from two
CHO cell clones expressing the Y925F FAK mutant (Y925F-1 and
Y925F-2), a clone overexpressing wild-type FAK (WT), and a
control clone (Neo), as indicated. Total cell lysate proteins were
Western blotted with the mAb KT3, which recognizes the epitope-
tagged exogenous FAK, the position of which is indicated by an
arrow. Molecular mass positions (kD) are shown on the right. (B)
Fibronectin-mediated cell migration of the above clones was ana-
lyzed using a NeuroProbe chemotaxis chamber. Cells in the up-
per chamber were allowed to migrate through a porous mem-
brane toward the lower chamber to which fibronectin had been
added at either 6 or 12 mg/ml. Cells that migrated through the mem-
brane were then fixed, stained, and counted using a light micro-
scope. Mean cell counts from at least 10 fields and three experi-
ments are shown. Error bars represent standard deviations. No
significant migration was observed in the absence of fibronectin
(not shown).
Figure 2. FAK expressed in CHO cells does not bind Grb2 in
vitro. (A) Cell lysates were prepared from a CHO control clone
(Neo) or clones expressing either wild-type (WT), Y397F, or
Y925F mutant FAK, as indicated. Total cell lysate proteins were
Western blotted with KT3 to demonstrate levels of FAK expres-
sion (Input). The lysates were used for an in vitro binding experi-
ment with the SH2 domains of Grb2 or Src expressed as recombi-
nant GST fusion proteins or with GST alone as a control. The
GST fusion proteins were immobilized on glutathione-Sepharose
beads with which the above lysates were incubated followed by
several washes with lysis buffer. Bound FAK was detected by
Western blotting with KT3. (B) Cell lysates were prepared from
293 cells that had been mock transfected or transiently trans-
fected with either pKH3-FAK or pCDM8-FAK, as indicated. To-
tal cell lysate proteins were Western blotted with anti-FAK to
demonstrate levels of FAK expression (Input). The lysates were
used for an in vitro binding assay with either GST-Grb2-SH2 or
GST, as above, and bound FAK was detected by Western blot-
ting with anti-FAK. 
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tion assays along with a WT clone and a control clone
(Neo), as shown in Fig. 3 
 
B.
 
 Again, the WT cells demon-
strated increased migration as compared with control cells.
However, neither clone expressing the P712/715A FAK mu-
tant exhibited increased migration on FN. These results
demonstrated that this proline-rich region of FAK is nec-
essary for its function and suggest that p130
 
Cas
 
 binding to
this site may mediate FAK-promoted cell migration.
To exclude the possibility that the lack of function of the
P712/715A FAK mutant was a result of gross alterations of
structure and/or kinase activity, the phosphorylation and
activity of this mutant were examined, as shown in Fig. 4.
Cell lysates were prepared from a representative clone ex-
pressing the P712/715A FAK mutant as well as a WT clone
and a control clone (Neo). The exogenous FAK was im-
munoprecipitated from the lysates using KT3, and the im-
mune complexes were Western blotted with KT3 (Fig. 4 
 
A
 
)
or the antiphosphotyrosine mAb PY20 (Fig. 4 
 
B
 
). Alterna-
tively, the KT3 immune complexes were subjected to in
vitro kinase assays either with (Fig. 4 
 
D
 
) or without (Fig. 4
 
C
 
) poly(Glu,Tyr) as an exogenous substrate. The P712/
715A FAK mutant demonstrated levels of in vivo tyrosine
phosphorylation (Fig. 4 
 
B
 
) and in vitro kinase activity to
the exogenous substrate (Fig. 4 
 
D
 
) similar to those of the
wild-type FAK, with a slightly higher level of in vitro auto-
phosphorylation (Fig. 4 
 
C
 
). The inability of the P712/715A
FAK mutant to promote cell migration was therefore not
a result of reduced kinase activity or phosphorylation.
We have previously demonstrated that Src binding to
Y397 of FAK is critical for FAK signaling in cell migration
processes (Cary et al., 1996). To exclude the possibility
that the mutation of P712/715A in FAK affected its ability
to associate with Src, we performed the following coimmu-
noprecipitation experiment. Cell lysates were prepared
from a WT, Y397F, P712/715A, or control clone. The ly-
sates were Western blotted with KT3 to demonstrate rela-
tive expression levels of exogenous FAK, which varied
somewhat in this particular experiment (Fig. 5 
 
A
 
). Alter-
natively, Src was immunoprecipitated from the lysates, and
the immune complexes were Western blotted with KT3 to
show exogenous FAK association with Src (Fig. 5 
 
B
 
). As
shown previously (Chan et al., 1994; Schaller et al., 1994;
Cary et al., 1996), the Y397F mutation resulted in signifi-
cantly reduced association of FAK with Src. However,
densitometric analysis showed that the P712/715A mutant
demonstrated a level of in vivo Src association comparable
to that of wild-type FAK and significantly higher than that
of the Y397F mutant, indicating that the inability of the
P712/715A FAK mutant to promote cell migration was not
a result of a secondary effect on Src association.
 
p130
 
Cas
 
 Phosphorylation Is Correlated with
FAK-promoted Cell Migration
 
The lack of function of the P712/715A mutant in promot-
Figure 3. The proline-rich p130Cas binding site on FAK is neces-
sary for FAK-promoted cell migration. (A) Cell lysates were gen-
erated from a control clone (Neo), a clone expressing wild-type
FAK (WT), or two independent clones expressing the P712/715A
FAK mutant (P712/715A-1 and P712/715A-2), as indicated. Total
cell lysate proteins were Western blotted with KT3 to demon-
strate comparable levels of FAK overexpression, the position of
which is indicated on the left by an arrow. Molecular mass posi-
tions (kD) are shown on the right. (B) Fibronectin-mediated cell
migration of the above clones was analyzed using a NeuroProbe
chemotaxis chamber as in Fig. 1. Mean cell counts from at least
nine fields and two experiments are shown. Error bars represent
standard deviations. No significant migration was observed in the
absence of FN (not shown).
Figure 4. The P712/715A
FAK mutant demonstrates
efficient kinase activity and
tyrosine phosphorylation.
Cell lysates were generated
from a control clone (Neo) or
clones expressing either wild-
type (WT) or P712/715A
FAK, as indicated. The exog-
enous FAK was immunopre-
cipitated using KT3, and the
immune complexes were
Western blotted with either
KT3 (A) or the antiphospho-
tyrosine mAb PY20 (B). Al-
ternatively, the immune com-
plexes were subjected to in
vitro kinase assays using
[g-32P]ATP in the absence
(C) or presence (D) of
poly(Glu,Tyr) (E4Y1) as an
exogenous substrate, the po-
sition of which is indicated
on the right.The Journal of Cell Biology, Volume 140, 1998 216
ing cell migration suggested that FAK binding to p130Cas
may be important in triggering downstream signaling path-
ways resulting in cell migration. To test this hypothesis, we
first examined association of exogenous FAK and its mu-
tants with p130Cas in CHO cells. Cell lysates were prepared
from a control clone or clones expressing either WT, KD,
Y397F, or P712/715A mutant FAK. A fraction of each ly-
sate was Western blotted with KT3 to verify similar ex-
pression levels of exogenous FAK in these clones (Fig. 6 A).
The remaining lysates were used for immunoprecipita-
tions with anti-p130Cas, and the immune complexes were
Western blotted with KT3 to detect p130Cas-associated
FAK (Fig. 6 B). Consistent with previous reports (Polte
and Hanks, 1995, 1997; Harte et al., 1996), the wild-type
FAK was associated with p130Cas. The kinase-defective
and Y397F FAK mutants were found to associate with
p130Cas as efficiently as wild-type FAK. In contrast, the
P712/715A FAK mutant showed a decreased association
with p130Cas, as observed previously (Polte and Hanks,
1997). Densitometric analysis of four such experiments in-
dicated an z50% reduction in P712/715A mutant associa-
tion with p130Cas relative to wild-type FAK.
Besides directly binding to FAK, p130Cas has also been
demonstrated to be tyrosine phosphorylated in response
to cell adhesion in a FAK- and Src-dependent manner
(Vuori et al., 1996). However, it is not clear if p130Cas bind-
ing to FAK is required for its phosphorylation. We there-
fore examined whether FAK overexpression in CHO cells
could promote p130Cas phosphorylation and whether this
was dependent on either the p130Cas binding site or the Src
binding site. Cell lysates were prepared from cells overex-
pressing FAK (WT, KD, Y397F, or P712/715A) or a con-
trol clone (Neo) as described in Materials and Methods.
Lysates were immunoprecipitated with anti-p130Cas, and
the immune complexes were Western blotted with anti-
p130Cas to verify similar expression levels (Fig. 7 B) or with
PY20 to determine the in vivo tyrosine phosphorylation
levels of p130Cas (Fig. 7 A). Overexpression of wild-type
FAK resulted in increased tyrosine phosphorylation of
p130Cas in CHO cells, and this was dependent on the
p130Cas binding site since it was abolished by the P712/
715A FAK mutation. Furthermore, the Y397F FAK mu-
tant did not promote p130Cas phosphorylation, suggesting
a role for Src binding to FAK in the increased p130Cas
phosphorylation. Consistent with this, p130Cas phosphory-
lation was also elevated by the KD FAK mutant, which
has been shown to associate with Src and promote CHO
cell migration (Cary et al., 1996). Therefore, increased
p130Cas phosphorylation required FAK binding to both
Src and p130Cas, and it was correlated with increased cell
migration in FAK-overexpressing CHO cells.
p130Cas is an adaptor protein containing multiple ty-
rosine phosphorylation sites (Sakai et al., 1994; Schlaepfer
et al., 1997); therefore, we examined the interaction of ty-
rosine-phosphorylated p130Cas with its potential down-
stream effectors. The same lysates described above were
used for in vitro binding experiments with various SH2 do-
mains expressed as GST fusion proteins or with GST alone
as a control, and the associated p130Cas was detected by
Western blotting (Fig. 7, C–F). The increased tyrosine
phosphorylation of p130Cas in cells expressing wild-type or
kinase-defective FAK correlated with its increased bind-
ing to the SH2 domains of Src, Nck, or the p85 subunit of
phosphatidylinositol 3-kinase, whereas in the absence of
increased p130Cas phosphorylation (in cells expressing the
Y397F or P712/715A FAK mutant), there was a basal level
of p130Cas binding to these SH2 domains. These results
suggested that increased association of p130Cas with SH2
domain–containing intracellular signaling molecules may
be responsible for triggering downstream signaling path-
ways in cell migration.
The Erk Signaling Pathway Does Not Mediate
FAK-promoted Cell Migration
Activation of Erks has been suggested to be one of the
possible downstream pathways of p130Cas (Schlaepfer et al.,
1997). To investigate the potential role of Erks in FAK-
promoted cell migration, we first examined whether stable
overexpression of FAK in CHO cells could activate Erks,
as shown in Fig. 8 A. A clone expressing wild-type FAK
(WT) or a control clone (Neo) were lysed as either a mono-
layer of attached cells (Att) or in suspension (Sus). As a
control for Erk activation, NIH 3T3 cells were lysed after
treatment with PDGF. Lysates were Western blotted with
anti–phospho-MAPK antibody, which recognizes the phos-
phorylated and activated forms of Erk1 and Erk2. PDGF
treatment of NIH 3T3 cells resulted in strong activation of
both Erk1 and Erk2, as indicated. While attached CHO
cells demonstrated increased Erk activation compared with
cells in suspension, there was no detectable Erk activation
Figure 5. A mutation of the
p130Cas binding site on FAK
does not affect its association
with Src. Cell lysates were
prepared from a control clone
(Neo) or from clones ex-
pressing either wild-type
(WT), Y397F, or P712/715A
FAK, as indicated. Total cell
lysate proteins were West-
ern blotted with KT3 to dem-
onstrate relative levels of
exogenous FAK expression (A). Alternatively, Src was immuno-
precipitated from the lysates using the anti-Src mAb 2-17, and
the immune complexes were Western blotted with KT3 to dem-
onstrate Src-associated FAK (B).
Figure 6. The P712/715A
FAK mutant demonstrates
reduced association with
p130Cas. Cell lysates from a
control clone (Neo), a clone
expressing wild-type FAK
(WT), or clones expressing
the indicated FAK mutants
(kinase-defective [KD], Y397F,
or P712/715A) were prepared using modified RIPA lysis buffer.
Total cell lysate proteins were Western blotted with KT3 to dem-
onstrate relative levels of exogenous FAK expression (A). The
lysates were used for immunoprecipitations using anti-p130Cas,
followed by Western blotting with KT3 to demonstrate p130Cas-
associated FAK (B).Cary et al. p130Cas in Focal Adhesion Kinase-promoted Cell Migration 217
as a result of FAK overexpression. We were unable to de-
tect activation of Erks in CHO cells replated on fibronec-
tin, regardless of FAK overexpression (data not shown).
These results suggested that Erks are not important medi-
ators of FAK signaling resulting in cell migration.
Although no FAK-dependent Erk activation was de-
tected, it was possible that Erks were activated to a low
and undetectable level by FAK overexpression and there-
fore could mediate FAK signal transduction resulting in
cell migration. To rule out this possibility, we examined
the ability of CHO cells to migrate in the presence of the
MEK inhibitor PD98059, which subsequently inhibits both
Erk1 and Erk2. CHO cells overexpressing wild-type FAK
(WT) or control cells (Neo) were subjected to FN-stimu-
lated cell migration assays in the presence of PD98059 at
the indicated concentrations (Fig. 8 B). This inhibitor did
not affect FAK-promoted cell migration at concentrations
necessary for inhibition of MEK1 and MEK2 (Alessi et al.,
1995; Dudley et al., 1995; Pang et al., 1995). These results
suggest that p130Cas may target signaling pathways other
than those involving Erks in mediating FAK-promoted
cell migration.
p130Cas Is an Important Mediator of FAK-promoted 
Cell Migration
While the above results demonstrating the lack of migra-
tion by the P712/715A FAK mutant and the correlation of
FAK-promoted p130Cas phosphorylation with migration
strongly suggested that p130Cas was a crucial downstream
mediator of FAK in cell migration, the possibility existed
that another protein that could bind FAK at this site could
be mediating this signaling. To confirm the role of p130Cas
in FAK-promoted cell migration, we expressed wild-type
p130Cas in cells overexpressing FAK (WT cells) to deter-
mine if this would further enhance cell migration. The ex-
pression vector pRc/CMV-Cas(Myc) was cotransfected with
pREP3 to WT cells, and stable hygromycin-resistant clones
were selected and screened for exogenous p130Cas expres-
sion using the mAb 9E10, which recognizes the epitope-
tagged p130Cas. Three such clones (WT/Cas-1, 2, and 3)
demonstrated similar levels of exogenous FAK expression
(Fig. 9 A) and exogenous p130Cas expression (Fig. 9 B).
The ability of these clones to migrate on FN was examined
as shown in Fig. 9 C. At 3 mg/ml FN, all three WT/Cas
Figure 7. FAK-promoted tyrosine phosphorylation of p130Cas
and its subsequent binding to SH2 domain–containing proteins
may mediate FAK-promoted cell migration. Cells overexpressing
FAK (wild-type [WT] or the mutants kinase-defective [KD], Y397F,
or P712/715A) or a control clone (Neo) were treated with sodium
vanadate and lysed. Lysates were used for immunoprecipitations
with anti-p130Cas, and the immune complexes were Western blot-
ted with PY20 (A) or anti-p130Cas (B). The SH2 domains of Src
(D), Nck (E), or the p85 subunit of phosphatidylinositol 3-kinase
(F) were expressed as recombinant bacterial GST fusion pro-
teins, or GST alone (C) was expressed as a control. The GST fu-
sion proteins were immobilized on glutathione-Sepharose beads,
with which the above cell lysates were incubated followed by sev-
eral washes with lysis buffer. Bound p130Cas was detected by West-
ern blotting with anti-p130Cas.
Figure 8. The Erk signaling pathway does not mediate FAK-pro-
moted cell migration. (A) Cells overexpressing wild-type FAK
(WT) or control cells (Neo) were lysed as either a monolayer of
attached cells (Att) or in suspension (Sus). As a control for Erk
activation, NIH 3T3 cells were serum-starved and treated with or
without PDGF (25 ng/ml for 10 min) followed by lysis. Total cell
lysate proteins were Western blotted with anti–phospho-MAPK
antibody. Arrows indicate the position of activated Erk1 and Erk2.
(B) WT or Neo cells were pretreated for 1 h with the indicated
concentrations of the MEK inhibitor PD98059, and their migra-
tion on 12 mg/ml FN was then analyzed using a chemotaxis cham-
ber. Mean cell counts from at least five fields and two experiments
are shown. Error bars represent standard errors.The Journal of Cell Biology, Volume 140, 1998 218
clones exhibited an increased level of migration as com-
pared with the WT clone. At higher FN concentrations,
these WT/Cas clones exhibited levels of migration compa-
rable to that of the WT clone (data not shown). These
results showed that FAK and p130Cas can cooperate to
promote cell migration and suggested that this may be a
result of direct interaction between the two proteins. How-
ever, it was possible that this effect was due to a second
p130Cas-initiated pathway that was independent of FAK.
To show that p130Cas is an important mediator of FAK-
promoted cell migration as a result of its direct association
with FAK, we expressed the SH3 domain of p130Cas
(CasSH3) in cells overexpressing FAK. CasSH3 was ex-
pected to bind to FAK and inhibit endogenous p130Cas
binding, thus acting in a dominant-negative manner. The
expression vector pKH3-CasSH3 was cotransfected with
pREP3 to WT cells. Stable hygromycin-resistant clones
were selected and screened for CasSH3 expression using
the mAb 12CA5, which recognizes the epitope-tagged
CasSH3. Two such clones (WT/CasSH3-1 and 2) demon-
strated similar levels of exogenous FAK expression (Fig.
10 A) and CasSH3 expression (Fig. 10 B). The association
of exogenous FAK with CasSH3 in these cells was con-
firmed by coimmunoprecipitation (Fig. 10 C). As shown in
Fig. 10 D, both WT/CasSH3 clones exhibited a reduced
level of migration as compared with the WT clone. These
results showed that p130Cas is an important downstream
mediator of FAK-promoted cell migration as a result of its
SH3 domain–dependent binding to FAK.
Discussion
FAK is a key player in integrin-mediated signal transduc-
Figure 9. Expression of p130Cas enhances FAK-promoted cell mi-
gration. Cell lysates were prepared from a clone expressing FAK
(WT), three clones expressing both FAK and wild-type p130Cas
(WT/Cas-1, 2, and 3), or a control clone (Neo), as indicated. Total
cell lysate proteins were Western blotted with mAb KT3 to dem-
onstrate exogenous FAK expression (A) or mAb 9E10 to demon-
strate exogenous p130Cas expression, which is indicated by an ar-
row (B). Molecular mass positions (kD) are shown on the right
(B). Migration of the above clones was analyzed using a chemo-
taxis chamber and 3 mg/ml FN as an attractant (C). Mean cell
counts from at least 20 fields and three experiments are shown.
Error bars represent standard errors.
Figure 10. Expression of the p130Cas SH3 domain and its associa-
tion with FAK inhibits FAK-promoted cell migration. Cell lysates
were prepared from a clone expressing FAK (WT), two clones
expressing both FAK and CasSH3 (WT/CasSH3-1 and 2), or a
control clone (Neo), as indicated. Total cell lysate proteins were
Western blotted with the mAb KT3 to demonstrate exogenous
FAK expression (A) or mAb 12CA5 to demonstrate expression
of the SH3 domain of p130Cas (B). Lysates were immunoprecip-
itated with KT3 and Western blotted with 12CA5 to show associ-
ation of exogenous FAK with CasSH3 (C). The position of
CasSH3 is indicated by arrows (B and C). Molecular mass posi-
tions (kD) are shown on the right (B). Migration of the above
clones was analyzed using a chemotaxis chamber and 12 mg/ml
FN as an attractant (D). Mean cell counts from at least 21 fields
and three experiments are shown. Error bars represent standard
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tion pathways; consistent with this it has been shown to as-
sociate with a number of important signaling molecules
(Clark and Brugge, 1995; Schwartz et al., 1995). However,
the functional significance of these interactions is largely un-
known in the context of appropriate cellular processes.
Recent studies have demonstrated that FAK plays a cru-
cial role in mediating integrin signal transduction resulting
in cell migration (Ilic et al., 1995; Cary et al., 1996; Gil-
more and Romer, 1996). Using a system of FAK overex-
pression in CHO cells, we are beginning to elucidate the
molecular mechanisms of FAK signaling in these pathways.
We have previously shown that Y397 is necessary for FAK’s
promotion of cell migration, implicating a role for Src and/or
PI 3-kinase downstream of FAK in these pathways (Cary
et al., 1996). In this report, we have analyzed the role of
FAK interaction with Grb2 and p130Cas, two signaling events
downstream of the FAK/Src complex. Our data excluded a
role for Grb2 binding to Y925 of FAK in FAK-promoted
cell migration. Conversely, we have identified p130Cas as a
mediator of FAK-promoted CHO cell migration in this sys-
tem. Unlike cells expressing wild-type FAK, cells express-
ing a FAK P712/715A mutant with reduced p130Cas associ-
ation showed a level of migration comparable to that of
control cells. Coexpression of p130Cas with FAK further
increased cell migration, and coexpression of the p130Cas
SH3 domain alone functioned as a dominant negative mu-
tant and decreased cell migration. Biochemical analysis
indicated that FAK expression in CHO cells increased ty-
rosine phosphorylation of p130Cas and its subsequent bind-
ing to several SH2 domains, which could stimulate down-
stream signaling pathways other than the Erk pathway to
mediate FAK-promoted cell migration.
One of the downstream events of the FAK/Src complex
formation is Src phosphorylation of Y925 of FAK and Grb2
binding to this site (Schlaepfer et al., 1994; Schlaepfer and
Hunter, 1996). FAK association with Grb2 is believed to
mediate activation of Erks in response to FN, which has
been well documented (Chen et al., 1994; Schlaepfer et al.,
1994; Zhu and Assoian, 1995). However, the putative role
of FAK in this pathway remains controversial. One report
has demonstrated that various FN fragments and integrin-
activating antibodies could activate Erk independently of
FAK tyrosine phosphorylation, suggesting that FAK does
not play a role in FN-stimulated Erk activation (Lin et al.,
1997). Conversely, FAK overexpression in human 293
cells significantly enhanced FN-stimulated Erk2 activation
(Schlaepfer and Hunter, 1997). In any case, our data here
demonstrated that Grb2 binding to Y925 of FAK was not
responsible for FAK-promoted cell migration. The Y925F
FAK mutant was able to promote cell migration as effi-
ciently as wild-type FAK (Fig. 1), and there was no detect-
able association of Grb2 with the transfected FAK in these
cells, which exhibit FAK-dependent increased cell mi-
gration (Fig. 2). Nevertheless, the binding of Grb2 to
FAK, which could result in activation of Erks, might play
a role in alternative integrin-mediated signal transduction
events, such as cell proliferation or cell survival (Frisch et
al., 1996; Gilmore and Romer, 1996; Hungerford et al.,
1996).
In this report, we provide several lines of evidence that
p130Cas is a downstream mediator of FAK-promoted cell
migration. First, a mutation of P712/715A in FAK abol-
ished its ability to promote CHO cell migration (Fig. 3).
The proline-rich region on FAK spanning amino acids
712–718 has been mapped as the primary binding site for
p130Cas through its SH3 domain (Polte and Hanks, 1995;
Harte et al., 1996), although a second proline-rich region
(amino acids 875–884) can also mediate FAK binding to
p130Cas (Harte et al., 1996; Polte and Hanks, 1997). In vivo
coimmunoprecipitation experiments showed that FAK/
p130Cas association was reduced but not abolished by the
P712/715A mutation (Fig. 6), indicating that the second
proline-rich region on FAK may mediate some binding to
p130Cas, as demonstrated previously (Harte et al., 1996;
Polte and Hanks, 1997). However, binding of p130Cas to an
alternative site clearly does not allow for FAK-promoted
migration. It has also been suggested that p130Cas may as-
sociate with FAK indirectly through Src (Schlaepfer et al.,
1997), which can bind FAK via its SH2 domain (Cobb et al.,
1994; Xing et al., 1994) and p130Cas via its SH3 domain
(Nakamoto et al., 1996). This is not the case in our CHO cell
system since a mutation of the Src binding site (Y397F)
did not affect FAK association with p130Cas (Fig. 6). Since
we have previously demonstrated that Src binding to FAK
is necessary for FAK-promoted migration (Cary et al.,
1996), we verified that the P712/715A FAK mutant did not
indirectly reduce Src association with FAK, thereby abol-
ishing FAK-promoted migration (Fig. 5). These results
therefore suggested that binding of p130Cas to the first pro-
line-rich region of FAK was necessary for FAK-promoted
cell migration. Second, coexpression of wild-type p130Cas
with FAK in CHO cells further enhanced the migration
promoted by FAK alone, indicating that these two pro-
teins can cooperate to promote cell migration (Fig. 9). These
results strongly suggested that the inability of the P712/
715A FAK mutant to stimulate cell migration was due to
its reduced association with p130Cas rather than some other
proteins that may bind to the same site on FAK. Finally,
coexpression of CasSH3 in CHO cells expressing FAK de-
creased cell migration (Fig. 10). The SH3 domain of
p130Cas has been mapped as the binding site for FAK pre-
viously (Polte and Hanks, 1995; Harte et al., 1996). Consis-
tent with this, we have found stable association of CasSH3
with exogenous FAK in vivo (Fig. 10 C). Furthermore, Na-
kamoto et al. (1997) have shown recently that truncation
of the SH3 domain of p130Cas abolished its localization to
focal contacts. It is therefore conceivable that CasSH3
bound to FAK was localized to focal contacts and could
function as a dominant-negative mutant by competing
with endogenous p130Cas for association with FAK and/or
localization to focal contacts. Together, these findings iden-
tify p130Cas as a downstream mediator of FAK-promoted
cell migration as a result of its SH3 domain–dependent as-
sociation with FAK.
Tyrosine phosphorylation of p130Cas as a result of its
binding to FAK is likely to play a role in its initiation of
signaling pathways resulting in cell migration. p130Cas has
been shown to be regulated by a number of different ty-
rosine kinases and phosphatases (Sakai et al., 1994, 1997;
Garton et al., 1996; Liu et al., 1996), and its phosphoryla-
tion in cell adhesion is believed to be dependent on both
FAK and Src (Vuori et al., 1996; Schlaepfer et al., 1997). It
has been shown that FAK expression can promote p130Cas
tyrosine phosphorylation (Vuori et al., 1996), which weThe Journal of Cell Biology, Volume 140, 1998 220
have confirmed in this study. Furthermore, we now dem-
onstrate that this phosphorylation is dependent on direct
binding of p130Cas to prolines 712 and 715 of FAK (Fig. 7).
While its binding to FAK is a direct interaction and not
dependent on Src, efficient tyrosine phosphorylation of
p130Cas in response to integrin activation is believed to re-
quire Src in this complex. Tyrosine phosphorylation of
p130Cas was decreased in cultured fibroblasts from Src2
mice and increased in Csk2 cells in which Src activity was
increased. In addition, it was shown that FAK-promoted
p130Cas phosphorylation was dependent on the Src binding
site (Y397) of FAK (Vuori et al., 1996). Both FAK and Src
could phosphorylate p130Cas in vitro at similar sites (Schlaep-
fer et al., 1997), leading us to question which kinase medi-
ates p130Cas phosphorylation in the FAK-overexpressing
CHO cells. We now demonstrate that FAK-promoted
p130Cas phosphorylation occurred when a kinase-defective
but not Y397F FAK mutant was expressed (Fig. 7), indi-
cating that Src may be the kinase that mediates phospho-
rylation of p130Cas in this system, as observed previously in
other cell types (Vuori et al., 1996). This result also sug-
gests that the inability of the Y397F FAK mutant to pro-
mote cell migration may be due to inefficient p130Cas phos-
phorylation and recruitment of signaling molecules.
The downstream pathway of p130Cas binding to FAK in
cell migration is unknown, although the activation of Erks
has been proposed as a possible signaling event down-
stream of p130Cas (Schlaepfer et al., 1997). Activation of Erks
could promote cell motility via regulation of gene expres-
sion, such as that described for the transcriptional regula-
tor NF-kB, the inhibition of which resulted in inhibition of
carcinoma cell migration on vitronectin (Yebra et al., 1995).
Additionally, recent evidence demonstrating that Erk2
could directly phosphorylate and activate myosin light chain
kinase indicates a more direct regulation of actin cytoskel-
etal proteins as a mechanism for Erk-dependent regula-
tion of cell motility (Klemke et al., 1997). However, our
data showed that Erks are not involved in FAK-promoted
cell migration in our CHO cell system. We have been un-
able to detect an increase in Erk activity by FAK overex-
pression (Fig. 8 A). Furthermore, studies using the MEK
inhibitor PD98059 have shown that inhibition of MEK ki-
nases and presumably Erks did not inhibit FAK-promoted
CHO cell migration on FN (Fig. 8 B). It is therefore possi-
ble that the Erk signaling pathway plays a role in cell mi-
gration in some cell types (Klemke et al., 1997) but not in
others (this study). These results also suggested that in
CHO cells, p130Cas is likely to target alternative downstream
signaling pathways as a result of its FAK-promoted ty-
rosine phosphorylation and subsequent recruitment of
other signaling molecules.
In conclusion, stable overexpression of FAK in CHO
cells has enabled us to dissect the molecular mechanisms
of FAK signal transduction and to analyze the putative
roles of several FAK-binding proteins and their down-
stream pathways in cell migration. We now demonstrate
that p130Cas, but not Grb2, is a mediator of FAK-pro-
moted cell migration. Our data also suggest that the FAK/
p130Cas complex targets downstream pathways other than
Erks in mediating FAK signaling in cell migration. Further
work will examine the importance of other protein associ-
ations with FAK as well as downstream signals from the
FAK/Src/p130Cas complex in integrin-mediated cell migra-
tion.
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